Effective coordination among multidisciplinary team and individualized management strategies has emerged as a cornerstone of optimal NET care.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Neuro-endocrine tumors (NET) resulting in syndromes of serotonin excess can lead to cardiac involvement, ...

To the Editor: Møller et al. (March 13 issue) 1 addressed the topic of the progression of carcinoid heart disease. Serial echocardiographic studies were available for 71 of the 273 referred patients.

Dr. Elliott Winford (Medicine): An 86-year-old man was admitted to this hospital because of shortness of breath. The patient had been in his usual state of health until 6 months before the current ...

First real-world experience of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET) since US FDA approval. Number of findings (dyspnea, lower extremity edema, pleural effusion, ...

Dr. Kimberly Perez and Dr. Jaydira Del Rivero discuss the new guideline from ASCO on symptom management for well-differentiated GEP-NETs. They share the latest recommendations on managing symptoms ...

Symptoms of neuroendocrine tumors (NETs) can vary depending on their location and severity. General symptoms include extreme fatigue, unexplained weight loss, and loss of appetite. NETs are a rare ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

As Crinetics prepares to make a tilt for FDA approval in a rare growth disorder later this year, a topline readout from a phase 2 study suggests the same drug also has the potential to treat symptoms ...